Top 10 Companies in Immunodiagnostics Market - Company Overview, Recent Developments and SWOT Analysis 2030

The Immunodiagnostics Market is driven by increased prevalence of infectious diseases, cardiovascular diseases, cancer, gastrointestinal diseases, and other chronic diseases, as well as changes in demography and lifestyle, are likely to drive the growth of the immunodiagnostics market over the forecast period. Furthermore, technological advancements in diagnosis kits, assays, and analyzers, as well as an increase in awareness of preventative health measures among patients and medical professionals, are a few of the factors expected to drive the growth of the immunodiagnostics market. Furthermore, technical advancements in diagnosis kits, assays, and analyzers, as well as increased awareness of preventive health measures among patients and medical professionals, generate demand for immunodiagnostics goods, driving growth. However, a number of obstacles are predicted to hinder market growth. The impact of the drivers is projected to be greater than the impact of the constraints. Furthermore, an increase in the impact of the drivers and restraints is expected to open up new market opportunities for key companies manufacturing immunodiagnostics products, particularly kits and assays.

Here are the top 10 companies operating in Immunodiagnostics Market

       

Founded in: 1888

Revenue in USD: 43.08 billion (2021)

Headquarter: Abbott Park, Illinois, U.S.

Number of Employees: 113,000 (2021)

Abbott Laboratories is a public company which is headquartered in Abbott Park, Illinois, U.S. Abbott Laboratories is an American multinational company. Abbott Laboratories is a medical devices & healthcare company. Abbott is the seller of branded generic medicines, medical devices, nutritional products, diagnostics, etc. In nutritional products Abbott provides adult nutrition product like ZonePerfect, Ensure, Pedialyte, MitraClip, Glucema, i-STAT, Freestyle Libre, BinaxNOW, etc.

 

         

Founded in: 1977

Headquarter: UK

Number of Employees: 286

Immunodiagnostic Systems Holdings PLC (IDS) is headquartered in UK. IDS is the developer, manufacturer and marketer of innovative immunoassays & automated immunoanalyser technologies which provides improved diagnostic outcomes for patients. The company’s immunoassay portfolio is the combination of endocrinology specialty testing menu, allergy, infectious diseases, and assay panels in auto immunity. The products are developed & manufactured in Europe. The company’s portfolio of specialized RIA & EIA immunoassays helps in delivering the innovative solutions for labs worldwide. Portfolio includes, growth assays, cartilage markers, research assays & offers complete bone metabolism. Automated product assays developed by company are: Urinary Cortisol, Calprotectin, SARS-CoV-2 S1-RBD IgG, Borrelia IgG and IgM Solution, Cortisol, Walnut, Soybean, Renin, Aldosterone, ACE, ACTH, Salivary Cortisol, and others. Manual product assays are: Spike Protein Inhibition Assay (SPIA), LISA-TRACKER anti-Trastuzumab, Dentien Discs, Bone Slices, Corticosterone EIA, Sac-Cel, and others.

Related:

Immunodiagnostic Systems Holdings PLC (IDS), has launched the newly developed fully automated immunoassays for use on IDS-ISYS Immunoanalyzer. Newly developed immunoassays are: Insulin-like Growth Factor (IGF-I), Parathyroid hormone (PTH) calcium biomarker, and Osteocalcin bone protein.

Founded in: 2000

Revenue in USD: 1,237.65 million (2021)

Headquarter: Saluggia, Italy

DiaSorin is an Italian multinational company. DiaSorin is the biotechnology company, which is the producer, marketer of in-vitro diagnostics reagent kits which are used in molecular diagnostics and immunodiagnostics. DiaSorin is also involved in Life Science business. The company’s production plants are located in United States and Europe. DiaSorin offers in-vitro diagnostics services and instruments. DiaSorin is also involved in development of research & laboratory kits which are used in molecular diagnostics, specialized in sector of infectious diseases with tests including mucus swabs, blood, cutaneous swabs, and cerebrospinal fluid. DiaSorin also focused in other field like endocrinology, autoimmunity, cardiac markers, oncology, hypertension, bone & mineral, gastrointestinal infections, etc.

Related:

In 2021, DiaSorin with CE mark has launched the ‘LIAISON SARS-CoV-2 TRIMERICS IgG test which is the new quantitative serology test used for determination of IgG antibodies against SARS-CoV-2, and deliver results with 98.7% sensitivity & 99.5% of specificity.

         

Founded in: 1886

Revenue in USD: 93.78 billion (2021)

Headquarter: New Brunswick, New Jersey, U.S.

Number of Employees: 144,500 (2021)

Johnson & Johnson is a public company which is headquartered in New Brunswick, New Jersey, U.S. Johnson & Johnson is an American multinational company. Johnson & Johnson is the developer of pharmaceutical products, medical devices, consumer packaged goods, etc. Johnson & Johnson is involved in various business sectors like in pharmaceutical sector includes – Immunology, neuroscience, cardiovascular & metabolic disease, infectious disease & vaccines, oncology, pulmonary hypertension, etc. Medtech sector includes – Orthopaedics Surgery, interventional solutions, etc. Consumer health sector includes – Medicines, baby care, women’s health, oral care, wound care, skin health, etc.

Immunodiagnostics Market is estimated to be US$ 39.69 billion by 2030 with a CAGR of 7.50% during the forecast period

Avail a sample market brochure of the report:

    

Founded in: 1896

Revenue in CHF: 62.80 billion (2021)

Headquartered in: Basel Switzerland

Number of Employees: 100,920 (2021)

F. Hoffmann-La Roche AG, is known as Roche. Roche is the Swiss multinational healthcare company. Roche operates under two sectors like diagnostics and pharmaceuticals. Roche has become the fifth largest pharmaceutical company in the world. Roche is the leading provider of cancer treatments worldwide. Roche is the developer of drugs used in cancer treatment, metabolic disease treatment, and virus disease treatment. Roche is the world’s largest spender in pharmaceutical research & development.

Related:

In 2022, Roche has launched the new diagnostic test ‘Elecsys IGRA SARS CoV-2 test’ for better understanding of Immune response to SARS-CoV-2. The new diagnostic test will provide a deeper understanding into immune response by identifying individual with adaptive T-cell response to SARS-CoV-2.

    

Founded in: 2017

Revenue in Euro: 18.0 billion (2021)

Headquartered in: Erlangen, Germany

Number of Employees: 66,000 (2021)

Siemens Healthineers AG is the German medical device company. Siemens Healthineers is the parent company for several medical technology company. Siemens Healthineers offer products in molecular diagnostics, magnetic resonance imaging, laboratory diagnostics, radiation oncology, X-ray products, molecular imaging, computed tomography, syngo imaging software, refurbished system services, angiography & interventional X-ray systems, point of care diagnostics, etc.

Related:

In 2022, Siemens Healthineers AG, has launched the two new combination test for seasonal respiratory pathogens and SARS-CoV-2. Newly launched test are – FTD SARS-CoV-2/FluA/FluB/HRSV PCR test will be enable to mid high throughput testing, semi-automated and comprehensive testing for common and serious seasonal respiratory pathogens. The CLINITEST Rapid COVID-19+ Influenza Antigen Test will help in delivering reliable results within 15 minutes for detecting Influenza and SARS-CoV-2.

 

Founded in: 1968

Revenue in JPY: 305.07 billion (2021)

Headquarters: Kobe, Hyogo, Japan

Number of Employees: 9,231 (2020)

Sysmex Corporation is the Japanese company which is involved in healthcare business. Sysmex Corporation offer products in health management support software, diagnostic instruments, and reagents. Sysmex is the distributor of its products in domestic as well as overseas market which includes, Germany, UK, U.S., Singapore, China, and others. The company offer unique solutions for protein expression, and deliver custom recombinant proteins.

Founded in: 1969 (as DMG) and 1984 (as Danaher)

Revenue in USD: 29.45 billion (2021)

Headquarters: Washington, D.C, U.S.

Number of Employees: 80,000 (2021)

Danaher Corporation, is an American company. Danaher is the designer, manufacturer, marketer of industrial, medical, and commercial products and services. Danaher has three platforms like diagnostics, life-sciences, environmental & applied solutions. Danaher is the seller of diagnostic products, instruments like flow cytometry, centrifuges, media analyzers, cell counters, automated liquid handling solutions, environmental monitoring instruments, and air particle counters, etc.

 

Founded in: 1956

Revenue in USD: 39.21 billion (2021)

Headquarters: Waltham, Massachusetts, U.S.

Number of Employees: 130,000 (2021)

Thermo Fisher Scientific Inc., is a public company. Thermo Fisher Scientific is the American company which supplies scientific instruments, software services, reagents and consumables. Thermo Fisher Scientific provides services for manufacturing of diagnostic and pharmaceutical products, drug discovery, research and development, analysis, etc.

 

             

Founded in: 1952

Revenue in USD: 2,922.55 million (2021)

Headquarters: Hercules, California, U.S.

Number of Employees: 7,900 (2021)

Bio-Rad Laboratories, Inc., is an American company. Bio-Rad Laboratories is the developer and manufacturer of specialized technological products for research, clinical diagnostics, and life science research. Bio-Rad Laboratories product includes, software, instruments, reagents, consumables, and content for areas like gene expression, cell biology, protein quantification, protein purification, drug discovery & manufacture, science education, food safety. The products are used for separation, purification, identification, analyzing & amplifying biological materials like proteins, antibodies, bacteria, cells, and nucleic acids.